Mina Piiksi D.
- Country
- Norway
- Department
- Department of Addiction Treatment
Research Overview
Data & Insights
Has run more than one trial at 0 of 2 partner sites.
Specializations
Metabolic Liver Disease and Fibrosis
Investigates therapeutic strategies for Non‑Alcoholic Steatohepatitis and associated metabolic liver injury.
- Anti‑fibrotic agents for NASH
- Metabolic risk modulation in obesity‑related liver disease
- Combination therapies targeting insulin resistance
Emphasis is placed on improving liver histology and preventing progression to cirrhosis.
Cardiovascular and Thrombotic Therapy
Focuses on prevention and treatment of acute and chronic cardiovascular events, including stroke and myocardial infarction.
- Antiplatelet and anticoagulant optimization after ischemic stroke
- Novel factor‑XI inhibitors for stroke risk reduction
- Management of venous thromboembolism in cancer patients
Targets reduction of recurrent ischemic events while minimizing bleeding complications.
Neuropsychiatric Disorders and Substance Use
Addresses co‑occurring mental health conditions and addiction, particularly alcohol use disorder.
- Ketamine‑based interventions for depression with comorbid AUD
- Integrated treatment models for benzodiazepine dependence in opioid agonist therapy
- Adjunctive therapies for chronic migraine and central nervous system disorders
Seeks to improve psychiatric outcomes while supporting sustained recovery from substance dependence.
Oncology and Precision Medicine
Explores targeted and immunologic approaches for a range of solid tumors and hematologic malignancies.
- Immune checkpoint inhibition in renal cell carcinoma
- Biomarker‑driven treatment selection for metastatic prostate cancer
- Precision drug repurposing for rare and hard‑to‑treat cancers
Integrates genomic profiling to tailor therapeutic regimens.
Infectious Diseases and Immune‑Mediated Conditions
Examines antiviral and immunomodulatory therapies for emerging infections and autoimmune cytopenias.
- Antiviral strategies for mpox virus disease
- Immunoglobulin‑based treatments for primary immune thrombocytopenia
- Hyperbaric oxygen as adjunct in acute sensorineural hearing loss
Prioritizes safety and efficacy in vulnerable patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.